Posted by Michael Wonder on 15 Sep 2022
FDA approves treatment to improve kidney function in adults with hepatorenal syndrome
14 September 2022 - FDA has approved Terlivaz (terlipressin) injection to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.
Terlivaz is the first FDA approved medication for this condition.
